Grafts and bone graft substitutes

Bone Regeneration and Repair: Biology and Clinical Applications

Volumn , Issue , 2005, Pages 133-156

  Sutherland, Doug ^a   Bostrom, Mathias ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33749466787     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1385/1-59259-863-3:133     Document Type: Chapter

References (162)

1. Andrew, J. G., Hoyland, J. A., Freemont, A. J., and Marsh, D. R. (1995) Platelet-derived growth factor expressed in normally healing human fractures. Bone 16, 455-460.
2. Ashton, B. A., Allen, T. D., Howlett, C. R., et al. (1980) Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin. Orthop. Rel. Res. 151, 294.
3. Beck, L. S., De Guzman, L., and Lee, W. P. (1995) Transforming growth factor-beta 1 bound to tricalcium phosphate persist at segmental radial defects and induces bone formation. Trans. Orthop. Res. Soc. 20, 593.
4. Beck, L. S., De Guzman, L., and Lee, W. P. (1996) Bone marrow augments the activity of transforming growth factor-beta 1 in critical sized defects. Trans. Orthop. Res. Soc. 21, 626.
5. Beresford, J. N. (1989) Osteogenic stem cells and the stromal system of bone and marrow. Clin. Orthop. Rel. Res. 240, 270.
6. Berrey, B. H., Lord, C. F., Gebhardt, M. C., and Mankin, H. J. (1990) Fractures in allografts. J. Bone Joint Surg. 72 A, 825-833.
7. Berrey, B. H., Lord, C. F., Gebhardt, M. C., and Mankin, H. J. (1990) Fractures of allografts. Frequency, treatment, and end-results. J. Bone Joint Surg. 72, 825-833. (Pubitemid 20246884)
8. Bland, Y. S., Critchlow, M. A., and Ashhurst, D. E. (1995) Exogenous fibroblast growth factors-1 and-2 do not accelerate fracture healing in the rabbit. Acta Orthop. Scand. 66, 543.
9. Blitch, E. and Ricotta, P. (1996) Introduction to bone grafting. J. Foot Ankle Surg. 35, 458-462. (Pubitemid 26378163)
10. Boden, S. D., Schimandle, J. H., and Hutton, W. C. (1995) Volvo award in basic science. the use of an osteoinductive growth factor for lumbar spinal fusion. Part I: Biology of spinal fusion. Spine 20, 2626-2632. (Pubitemid 26011069)
11. Boden, S. D., Schimandle, J. H., and Hutton, W. C. (1995) Volvo award in basic science. the use of an osteoinductive growth factor for lumbar spinal fusion. Part II: Study of dose, carrier, and species. Spine 20, 2633-2644. (Pubitemid 26011476)
12. Boden, S. D. (2001) Clinical application of the BMPs. J. Bone Joint Surg. 83 A (Suppl 1, Pt 2), S161.
13. Boden, S. D., Zdeblick, T. A., Sandhu, H. S., and Heim, S. E. (2000) The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 25(3), 376-381. (Pubitemid 30097051)
14. Bonucci, E. (1981) New knowledge of the origin, function and fate of osteoclasts. Clin. Orthop. Rel. Res. 158, 252-269. (Pubitemid 11040638)
15. Bruder, S. P., Fink, D. J., and Caplan, A. I. (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell Biol. 56, 283-294. (Pubitemid 24360045)
16. Bucholz, R. W. (1994) Development and clinical use of coral-derived hydroxyapatite bone graft substitutes, in Bone Grafts, Derivatives, and Substitutes (Urist, M. R., O'Connor, B. T., and Burwell, R. G., eds.), Butterworth-Heinemann, pp. 260-270.
17. Buck, B. E., Malinin, T., and Brown, M. D. (1989) Bone transplantation and human immunodeficiency virus. Clin. Orthop. 240, 129-136.
18. Bugbee, W. D. and Convery, F. R. (1999) Osteochondral allograft transplantation. Clin. Sports Med. 18, 67-75. (Pubitemid 29066060)
19. Buncke, H. J., Furnas, D. W., Gordon, L., and Achaner, B. (1977) Free osteocutaneous flap for the rib to the tibia. Plast. Reconstr. Surg. 59, 79-91.
20. Burchardt, H. (1983) The biology of bone graft repair. Clin. Orthop. Rel. Res. 174, 28-42. (Pubitemid 13122171)
21. Burchardt, H., Glowczewskie, F. P., and Ennecking, W. F. (1981) Short-term immunosupression with fresh segmental fibular allografts in dogs. J. Bone Joint Surg. 63 A, 411-415. (Pubitemid 11153708)
22. Den Boer, F. C., Bramer, J. A., Blokhuis, T. J., et al. (2002) Effect of recombinant human osteogenic protein-1 on the healing of a freshly closed diaphyseal fracture. Bone 31(1), 158-164. (Pubitemid 34754442)
23. Burgess, W. H. and Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Cell Dev. Biol. 58, 575-606. (Pubitemid 19172981)
24. Burwell, R. G. (1985) The function of bone marrow in the incorporation of a bone graft. Clin. Orthop. 200, 125-141. (Pubitemid 16138039)
25. Burwell, R. G. (1994) The Burwell theory on the importance of bone marrow in bone grafting, in Bone Grafts, Derivatives, and Substitutes (Urist, M. R., O'Connor, B. T., and Burwell, R. G., eds.), Butterworth-Heinemann, pp. 103-155.
26. Burwell, R. G., Friedlaender, G. E., and Mankin, H. J. (1985) Current perspectives and future directions: the 1983 invitational conference on osteochondral allografts. Clin. Orthop. 200, 141-157. (Pubitemid 15018926)
27. Carringtion, J. L., Roberts, A. B., Falnders, K. C., et al. (1988) Accumulation, localization, and compartmentation of transforming growth factor-B during endochondral bone development. J. Cell Biol. 107, 1969-1975.
28. Centrella, M., Horowitz, M. C., Wozney, J., and McCarthy, T. (1994) Transforming growth factor-beta gene family members and bone. Endocrinol. Rev. 15, 27.
29. Clark, R. A. F. (1996) The Molecular and Cellular Biology of Wound Repair. Plenum Press, New York.
30. Clarke, M. S. F., Khakee, R., and McNeil, P. L. (1993) Loss of cytoplasmic basic fibroblast growth factor for physiologically wounded myofibers of normal and dystrophic muscle. J. Cell Sci. 106, 121-133. (Pubitemid 23286784)
31. Connolly, J., Guse, R., Lippiello, L., and Dehne, R. (1989) Development of an osteogenic bone-marrow preparation. J. Bone Joint Surg. 71, 684-691. (Pubitemid 19179655)
32. Connolly, J., Guse, R., Tiedeman, J., and Dehne, R. (1991) Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin. Orthop. 266, 259-270.
33. Constantz, B. R., Ison, I. C., Fulmer, M. T., et al. (1995) Skeletal repair by in situ formation of the mineral phase of bone (see comments). Science 267, 1796-1799.
34. Cook, S. D., Baffes, G. C., Wolfe, M. W., Sampath, T. K., and Rueger, D. C. (1994) Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. 301, 304-312.
35. Cook, S. D., Baffes, G. C., Wolfe, M. W., et al. (1994) The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg. 76, 827-838. (Pubitemid 24213211)
36. Cook, S. D., Dalton, J. E., Tan, E. H., Whitecloud, T. S., and Rueger, D. C. (1994) In vivo evaluation of recombinant human osteogenic protein (rhOP-1) implants as a bone graft substitute for spinal fusions. Spine 19, 1655-1663. (Pubitemid 24314171)
37. Cook, S. D., Wolfe, M. W., Salkeld, S. L., and Rueger, D. C. (1995) Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J. Bone Joint Surg. 77, 734-750.
38. Critchlow, M. A., Bland, Y. S., and Ashhurst, D. E. (1995) The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 16, 521-527.
39. Cuevas, P., Burgos, J., and Baird, A. (1988) Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. Biochemical. Biophysical. Res. Commun. 156, 611-618. (Pubitemid 18263876)
40. Doi, K., Tominaga, S., and Shibata, T. (1977) Bone grafts with microvascular anastomoses of vascular pedicles. J. Bone Joint Surg. 59 A, 809-815. (Pubitemid 8191212)
41. Dreesmann, H. (1892) Ueber Knochenplombierung. Beitr. Klin. Chir. 9, 804-810.
42. Dunstan, C. R., Boyce, R., Boyce, B. F., et al. (1999) Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J. Bone Miner. Res. 14, 953-959. (Pubitemid 29262890)
43. Ekelund, A., Brosjo, O., and Nilsson, O. S. (1991) Experimental induction of heterotopic bone. Clin. Orthop. Rel. Res. 263, 102.
44. Enneking, W. F., Eady, J. L., and Burchardt, H. (1980) Autogenous cortical bone grafts in the reconstruction of segmental skeletal defects. J. Bone Joint Surg. 62 A, 1039-1058. (Pubitemid 10024535)
45. Enneking, W. F. and Mindell, E. R. (1991) Observations on massive retrieved human allografts. J. Bone Joint Surg. 73 A, 1123-1142.
46. Esch, F., Baird, A., Ling, N., et al. (1985) Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino terminal sequence of bovine brain acidic FGF. Proc. Natl. Acad. Sci. USA 82, 6507-6511. (Pubitemid 16230543)
47. Fager, G., Hansson, G. K., Ottosson, P., Dahllof, B., and Bondjers, G. (1988) Human arterial smooth muscle cells in culture: effects of platelet derived growth factor and heparin on growth in vitro. Exp. Cell Res. 176, 319-335.
48. Flynn, J. M., Springfield, D. S., and Mankin, H. J. (1994) Osteoarticular allografts to treat distal femoral osteonecrosis. Clin. Orthop. 303, 38-43. (Pubitemid 24173786)
49. Friedlaender, G. E., Perry, C. R., Cole, J. D., et al. (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J. Bone Joint Surg. American Volume 83A(Suppl 1, Pt 2), S151-S158.
50. Fujimori, Y., Nakamura, T., Ijiri, S., Shimizu, K., and Yamamuro, T. (1992) Heterotopic bone formation induced by bone morphogenetic protein in mice with collagen-induced arthritis. Biochem. Biophys. Res. Commun. 186, 1362-1367. (Pubitemid 23189474)
51. Galzie, Z., Kinsella, A. R., and Smith, J. A. (1997) Fibroblast growth factors and their receptors. Biochem. Cell Biol. 75, 669-685. (Pubitemid 127733222)
52. Geesink, R. G., Hoefnagels, N. H., and Bulstra, S. K. (1999) Osteogenic activity of OP-1 bone morphogenetic protein (BMP-7) in a human fibular defect. J. Bone Joint Surg. 81(4), 710-718.
53. Gerhart, T., Kirker-Head, C., Kriz, M., et al. (1991) Healing of large mid-femoral segmental defects in sheep using recombinant human bone morphogenetic protein (BMP-2). Trans. Orthop. Res. Soc. 16, 172.
54. Glowacki, J., Jasty, M., and Goldring, S. (1986) Comparison of multinucleated cells elicited in rats by particulate bone, polyethylene, or polymethylmethacrylate. J. Bone Miner. Res. 1, 327.
55. Goel, S. C. and Tuli, S. M. (1994) Use of decalbone in healing of osseous cystic defects, in Bone Grafts, Derivatives, and Substitutes (Urist, M. R., O'Connor, B. T., and Burwell, R. G., eds.), Butterworth-Heinemann, pp. 210-219.
56. Gospodarowicz, D. (1974) Localisation of fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth. Nature 249, 123-129.
57. Gospodarowicz, D., Bialecki, H., and Greenburg, G. (1978) Purification of fibroblast growth factor activity from bovine brain. J. Biol. Chem. 253, 3736-3743. (Pubitemid 8346572)
58. Govender, S., Csimma, C., Genant, H. K., et al. (2002) BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. 84 A (12), 2123-2134. (Pubitemid 35417689)
59. Hammack, B. L. and Enneking, W. F. (1960) Comparative vascularization of autogenous and homogenous bone transplants. J. Bone Joint Surg. 42 A, 811.
60. Han, C. S., Wood, M. B., Bishop, A. D., et al. (1992) Vascularized bone transfer. J. Bone Joint Surg. 74 A, 1441-1449. (Pubitemid 23046760)
61. Heckman, J. D., Aufdemorte, T. B., and Athanasiou, K. A. (1995) Treatment of acute ostectomy defects in the dog radius with TGF-B1. Trans. Orthop. Res. Soc. 20, 590.
62. Hench, L. L. (1992) Bioactive bone substitutes, in Bone Grafts and Bone Graft Substitutes (Habal, M. B. and Reddi, A. H., eds.), Saunders, Philadelphia, pp. 263-275.
63. Hofmann, G. O., Kirschner, M. H., Wagner, F. D., Brauns, L., Gonschorek, O., and Buhren, V. (1998) Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints-first clinical experiences. Transplant. Proc. 30, 2754-2761. (Pubitemid 28459815)
64. Hollinger, J. O. and Wong, M. E. (1996) The integrated processes of hard tissue regeneration with special emphasis on fracture healing. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 82, 594-606. (Pubitemid 126816424)
65. Hughes, A. D., Clunn, C. F., Refson, J., and Demoliou-Mason, C. (1996) Platelet-derived growth factor: actions and mechanisms in vascular smooth muscle. Genet. Pharm. 27, 1079-1089. (Pubitemid 26375419)
66. Hurley, M. M., Lee, S. K., Raisz, L. G., Bernecker, P., and Lorenzo, J. (1998) Basic fibroblast growth factor induces osteoclast formation in murine bone marrow cultures. Bone 22, 309-316. (Pubitemid 28177182)
67. Ibbotson, K. J., Harrod, J., Gowen, M., et al. (1986) Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro. Proc. Natl. Acad. Sci. USA 83(7), 2228-2232. (Pubitemid 16020868)
68. Iwata, H., Sakano, S., Itoh, T., and Bauer, T. W. (2002) Demineralized bone matrix and native bone morphogenetic protein in orthopaedic surgery. Clin. Orthop. Rel. Res. 395, 99-109. (Pubitemid 34136660)
69. Jaye, M., Schlessinger, J., and Dionne, C. A. (1992) Fibroblast growth factor receptor tyrosine kinase-molecular analysis and signal transduction. Biochem. Biophys. Acta 1135, 185-199.
70. Jingushi, S., Heydemann, A., Kana, S. K., Macey, L. R., and Bolander, M. E. (1990) Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing. J. Orthop. Res. 8, 364-371. (Pubitemid 20250859)
71. Johnson, E. E., Urist, M. R., and Finerman, G. A. (1988) Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. Clin. Orthop. 230, 257-265.
72. Johnson, E. E., Urist, M. R., and Finerman, G. A. (1988) Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. Clin. Orthop. 236, 249-257. (Pubitemid 18264725)
73. Johnson, E. E., Urist, M. R., and Finerman, G. A. (1992) Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. Clin. Orthop. 277, 229-237.
74. Joyce, M. E., Nemeth, G. G., Jingushi, S., et al. (1989) Expression and localization of transforming growth factor-B in a model of fracture healing. Orthop. Trans. 13(2), 460.
75. Kato, T., Kawaguchi, H., Hanada, K., et al. (1988) Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J. Orthop. Res. 16, 654-659.
76. Katthagen, B. D. and Mittelmeier, W. (1994) Clinical use of pyrost, in Bone Grafts, Derivatives, and Substitutes (Urist, M. R., O'Connor, B. T., and Burwell, R. G., eds.), Butterworth-Heinemann, pp. 220-234.
77. Kelly, C. M., Wilkins, R. M., Gitelis, S., Hartjen, C., Watson, J. T., and Kim, P. T. (2001) The use of a surgical grade calcium sulfate as a bone graft substitute: results of a multicenter trial. Clin. Orthop. Rel. Res. 382, 42-50. (Pubitemid 32047428)
78. Khan, S. N. Sandhu, H. S., Lane, J. M., Cammisa, F. P. Jr., and Girardi, F. P. (2002) Bone morphogenetic proteins: elevance in spine surgery. Orthop. Clin. N. Am. 33(2), 447-463, ix. (Pubitemid 34701291)
79. Kimmelman, D., Abraham, J., Haaparanta, T., Palisi, T., and Kirschner, M. (1988) The presence of fibroblast growth factor in the frog egg: its role as a natural mesoderm inducer. Science 242, 1053-1056.
80. Kimoto, T., Hosokawa, R., Kubo, T., et al. (1998) Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria-an application of a new drug delivery system. J. Dental Res. 77, 1965-1969. (Pubitemid 32770495)
81. Kirker-Head, C., Gerhart, T., Schelling, S., et al. (1995) Long-term healing of bone using recombinant human bone morphogenetic protein-2. Clin. Orthop. 318, 222-230.
82. Kirschner, M. H., Wagner, F. D., Nerlich, A. L., Buhren, V., and Hofmann, G. O. (1998) Allogenic grafting of vascularized bone segments under immunosuppression. Clinical results in the transplantation of femoral diaphyses. Transplant Int. 11, 195-203. (Pubitemid 28239372)
83. Kish, G., Modis, L., and Hangody, L. (1999) Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Rationale, indications, techniques, and results. Clin. Sports Med. 18, 45-66. (Pubitemid 29066059)
84. Kopylov, P. (1999) Norian SRS versus external fixation in redisplaced distal radial fractures. A randomized study in 40 patients. Acta Orthop. Scand. 70, 1-5. (Pubitemid 29119109)
85. Kumta, S. M., Leung, P. C., Griffith, J. F., et al. (1998) A technique for enhancing union of allograft to host bone. J. Bone Joint Surg. 80 B, 994-998. (Pubitemid 28528401)
86. Kuznetsov, S. A. Krebsbach, P. H. Satomura, K., et al. (1997) Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12, 1335-1347. (Pubitemid 27375376)
87. Lane, J. M., Yasko, A. W., Tomin, E., et al. (1999) Bone marrow and recombinant human bone morphogenetic protein-2 in osseous repair. Clin. Orthop. Rel. Res. 361, 261-227.
88. Lee, W. P., Rubin, J. P., Cober, S., Ierino, F., Randolph, M. A., and Sachs, D. H. (1998) Use of swine model in transplantation of vascularized skeletal tissue allografts. Transplant. Proc. 30, 2743-2745. (Pubitemid 28459813)
89. Lexer, E. (1925) Joint transplantation and arthroplasty. Surg. Gynecol. Obstet. 40, 782-809.
90. Lind, M., Schumacker, B., Soballe, K., et al. (1993) Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop. Scand. 64, 553.
91. Lieberman, J. R., Daluiski, A., and Einhorn, T. A. (2002) The role of growth factors in the repair of bone. Biology and clinical applications. J. Bone Joint Surg. 84 A (6), 1032-1044.
92. Lorentzon, R., Alfredson, H., and Hildingsson, C. (1998) Treatment of deep cartilage defects of the patella with periosteal transplantation. Knee Surg. Sports Traum. Arthroscopy 6, 202-208. (Pubitemid 128548658)
93. Macewen, W. (1909) Intrahuman bone grafting and reimplantation of bone. Ann. Surg. 50, 959-968.
94. Mankin, H. J., Springfield, D. S., Gebhardt, M. C., and Tomford, W. (1992) Current status of allografting for bone tumors. Orthopedics 15, 1147-1154.
95. Marx, R. E., Carlson, E. R., Eichstaedt, R. M., Schimmele, S. R., Strauss, J. E., and Georgeff, K. R. (1998) Plateletrich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodont. 85, 638-646. (Pubitemid 128641964)
96. Meyers, M. H. and Chatterjee, S. N. (1978) Osteochondral transplantation. Surg. Clin. N. Am. 58, 429-434. (Pubitemid 9045384)
97. Mirzayan, R., Panossian, V., Avedian, R., Forrester, D. M., and Menendez, L. R. (2001) The use of calcium sulfate in the treatment of benign bone lesions. A preliminary report. J. Bone Joint Surg. 83 A (3), 355-358. (Pubitemid 32221564)
98. Moed, B. R., Willson Carr, S. E., Craig, J. G., and Watson, J. T. (2003) Calcium sulfate used as bone graft substitute in acetabular fracture fixation. Clin. Orthop. Rel. Res. 410, 303-309. (Pubitemid 36538577)
99. Morrison, S. J., Uchida, N., and Weissman, I. L. (1995) The biology of hematopoietic stem cells. Ann. Rev. Cell Dev. Biol. 11, 35-71. (Pubitemid 26019601)
100. Morrison, S. J., Wandycz, A. M., Akashi, K., Globerson, A., and Weissman, I. L. (1996) The aging of hematopoietic stem cells. Nat. Med. 2, 1011-1016. (Pubitemid 26306840)
101. Muschler, G. F., Boehm, C., and Easley, K. (1997) Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J. Bone Miner. Res. 79, 1699-1709. (Pubitemid 27508530)
102. Muschler, G. F., Hyodo, A., Manning, T., Kambic, H., and Easley, K. (1994) Evaluation of recombinant human bone morphogenetic protein-2 in a canine fusion model. Clin. Orthop. 308, 229-240. (Pubitemid 24349333)
103. Nakahara, H., Goldberg, V. M., and Caplan, A. I. (1992) Culture-expanded periosteal-derived cells exhibit osteochondrogenic potential in porous calcium in vivo. Clin. Orthop. 276, 291-298.
104. Nakajima, F., Yamazaki, M., Ogasawara, A., et al. (1998) Enhancement of experimental fracture healing with a local injection of basic fibroblast growth factor. Trans. Orthop. Res. Soc. 23, 596.
105. Nakamura, T., Hara, Y., Tagawa, M., et al. (1998) Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J. Bone Miner. Res. 13, 942.
106. Nash, T. J., Howlett, C. R., Martin, C., et al. (1994) Effect of platelet derived growth factor on tibial osteotomies in rabbits. Bone 15, 203.
107. Nielsen, H. M., Andreassen, T. T., Ledet, T., and Oxlund, H. (1994) Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop. Scand. 65, 37.
108. Ohlendorf, C., Tomford, W., and Mankin, H. J. (1996) Chondrocyte survival in cryopreserved osteochondral articular cartilage. J. Orthop. Res. 14, 413-416. (Pubitemid 26199830)
109. Ornitz, D. M., Yayon, A., Flanagan, J. G., et al. (1992) Heparin is required for cell free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell Biol. 12, 240-247.
110. Owen, M. (1980) The origin of bone cells in the postnatal organism. Arthrit. Rheum. 23, 1074.
111. Paley, D., Young, M. C., Wiley, A. M., et al. (1986) Percutaneous bone marrow grafting of fractures and bony defects: an experimental study in rabbits. Clin. Orthop. Rel. Res. 208, 300.
112. Partio, E. K., Tuompo, P., Hirvensalo, E., Bostman, O., and Rokkanen, P. (1997) Totally absorbable fixation in the treatment of fractures of the distal femoral epiphyses. A prospective clinical study. Arch. Orthop. Trauma Surg. 116, 213-216. (Pubitemid 27168315)
113. Pasquale, E. B. and Singer, S. J. (1989) Identification of a developmentally regulated protein tyrosine kinase by using anti-phosphotyrosine anitbodies to screen a cDNA expression library. Proc. Natl. Acad. Sci. USA 86, 5449-5453. (Pubitemid 19185566)
114. Peltier, L. F. (1961) The use of plaster of paris to fill defects in bone. Clin. Orthop. 21, 1-31.
115. Peltier, L. F. and Speer, D. (1992) Calcium sulfate, in Bone Grafts and Bone Graft Substitutes (Habal, M. B. and Reilly, M. J., eds.), Saunders, Philadelphia, pp. 243-246.
116. Peltier, L. F. (2001) The use of plaster of Paris to fill large defects in bone: a preliminary report. 1959. Clin. Orthop. Rel. Res. 382, 3-5.
117. Peterson, D. L., Glancy, T. P., and Bacon-Clarke, R. (1997) A study of delivery timing and duration of the transforming growth factor-beta 1 induced healing of critical-sized long bone defects. J. Bone Miner. Res. S304.
118. Pihlajamaki, H., Kinnunen, J., and Bostman, O. (1997) In vivo monitoring of the degradation process of bioresorbable polymeric implants using magnetic resonance imaging. Biomaterials 18, 1311-1315. (Pubitemid 27406137)
119. Praemer, M. A., Furner, S., and Rice, D. P. (1992) Musculoskeletal conditions in the united states. American Academy of Orthopaedic Surgeons, Park Ridge, IL.
120. Radomsky, M. L., Aufdemorte, T. B., Swain, L. D., et al. (1999) Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J. Orthop. Res. 17, 607-614. (Pubitemid 29383624)
121. Radomsky, M. L., Thompson, R. C., Spiro, R. C., and Poser, J. W. (1998) Potential role of fibroblast growth factor in enhancement of fracture healing. Clin. Orthop. 355 S, 283.
122. Ray, R. D. (1972) Bone grafts and bone implants. Otolaryngol. Clin. N. Am. 5, 389.
123. Ray, R. D. (1972) Vascularization of bone graft and implants. Clin. Orthop. 87, 43-48.
124. Ray, R. D. S. T. (1963) Bone grafts: cellular survival versus induction-an experimental study. J. Bone Joint Surg. 33 A, 873.
125. Reddi, A. H. (1992) Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr. Opin. Cell Biol. 4, 850-855.
126. Rifkin, D. B. and Moscatelli, D. (1989) Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109, 1-6. (Pubitemid 19180114)
127. Rosier, R. N., O'Keefe, R. J., and Hicks, D. G. (1998) The potential role of transforming growth factor-beta in fracture healing. Clin. Orthop. 355 S, 294.
128. Rosier, R. N., O'Keefe, R. J., and Hicks, D. G. (1998) The potential role of transforming growth factor beta in fracture healing. Clin. Orthop. 355 S, 294-301.
129. Sakou, T. (1998) Bone morphogenetic proteins: from basic studies to clinical approaches. Bone 22, 591-603. (Pubitemid 28284607)
130. Salama, R., Burwell, R. G., and Dickson, I. R. (1973) The beneficial effect upon osteogenesis of impregnated xenograft (heterograft) bone with autologous red marrow. J. Bone Joint Surg. 55 B, 402-417.
131. Salama, R. and Weissman, I. L. (1978) The clinical use of combined xenografts of bone and autologous red marrow. J. Bone Joint Surg. 60 B, 111-115. (Pubitemid 8298419)
132. Sandhu, D. J., Kanim, L. E., Kabo, J. M., et al. (1995) Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model. Spine 20, 2669-2682. (Pubitemid 26011073)
133. Schaffer, J. W., Field, G. A., Goldberg, V. M., and Davy, D. (1985) Fate of vascularized and non-vascularized autografts. Clin. Orthop. 197, 32-43.
134. Schimandle, J. H. and Boden, S. D. (1994) The use of animal models to study spinal fusion. Spine 19, 1998-2006. (Pubitemid 24321331)
135. Schimandle, J. H., Boden, S. D., and Hutton, W. C. (1995) Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 20, 1326-1337.
136. Schmitt, J. M., Hwang, K., Winn, S. R., and Hollinger, J. O. (1999) Bone morphogenetic proteins: an update on basic biology and clinical relevance. J. Clin. Orthop. Res. 17, 269-278. (Pubitemid 29190501)
137. Seifert, R. A., Hart, C. E., Phillips, P. E., et al. (1989) Two different subunits associate to create isoform-specific platelet derived growth factor receptors. J. Biol. Chem. 264, 8771-8778. (Pubitemid 19151598)
138. Slack, J. M. W., Isaacs, H. V., and Darlington, B. G. (1988) Inductive effects of FGF and lithium ion on xenopus blastula ectoderm. Development 103, 581-590.
139. Stevenson, S. (1998) Enhancement of fracture healing with autogenous and allogeneic bone grafts. Clin. Orthop. Rel. Res. 355 S, S239-S246.
140. Takagi, K. I. and Urist, M. R. (1982) The role of bone marrow in bone morphogenetic protein-induced repair of femoral massive diaphyseal defects. Clin. Orthop. Rel. Res. 171, 224.
141. Takao, Y. (1994) Bone bonding behavior and clinical use of A-W glass-ceramic, in Bone Grafts, Derivatives and Substitutes (Urist, M. R., O'Connor, B. T., and Burwell, R. G., eds.), Butterworth-Heinemann Ltd, pp. 245-259.
142. Taylor, G. I., Miller, G. D. H., and Ham, F. J. (1973) The free vascularized bone graft, a clinical extension of microvascular techniques. Plast. Reconstr. Surg. 55, 533.
143. Thompson, R. C., Pickvance, E. A., and Garry, D. (1993) Fractures in large-segmented allografts. J. Bone Joint Surg. 75 A, 1663-1673.
144. Tiedeman, J., Connolly, J., Strates, B. S., and Lippiello, L. (1991) Treatment of nonunion by percutaneous injections of bone marrow and demineralized bone matrix. An experimental study in dogs. Clin. Orthop. 268, 294-302.
145. Tomford, W., Springfield, D. S., and Mankin, H. J. (1992) Fresh and frozen articular cartilage allografts. Orthopedics 15, 1183-1188.
146. Tomford, W., Thongphasuk, J., Mankin, H. J., and Ferraro, M. J. (1990) Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J. Bone Joint Surg. 72, 1137-1143. (Pubitemid 20343158)
147. Toriumu, D. M., Kotler, H. S., Luxenberg, D., Holtrop, M. E., and Wang, E. (1991) Mandibular reconstruction with a recombinant bone-inducing factor. functional, Histologic, and biomechanical evaluation. Arch. Otolaryngol. Head Neck Surg. 117, 1101-1112.
148. Urist, M. R. (1965) Bone: formation by autoinduction. Science 150, 893-899.
149. Urist, M. R. and Strates, B. S. (1971) Bone morphogenetic protein. J. Dental Res. 50, 1392-1406.
150. Urist, M. R., Hay, P. H., Dubuc, F., and Buring, K. (1969) Osteogenetic competence. Clin. Orthap. Rel. Res. 64, 194-218.
151. Valentin-Opran, A., Wozney, J., Csimma, C., Lilly, L., and Riedel, G. E. (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin. Orthop. Rel. Res. 395, 110-120. (Pubitemid 34136661)
152. Van Meekeren, J. (1668) Heel-en Geneeskonstige Aanmerkingen. Commelijn.
153. Walsh, W. R., Morberg, P., Yu, Y., et al. (2003) Response of a calcium sulfate bone graft substitute in a confined cancellous defect. Clin. Orthop. Rel. Res. 406, 228-236. (Pubitemid 36083903)
154. Weiland, A. J., Moore, J. R., and Daniel, R. K. (1983) Vascularized bone autografts, experience with 41 cases. Clin. Orthop. 174, 87-95. (Pubitemid 13122176)
155. Wlodarski, K. H. (1990) Properties and origin of osteoblasts. Clin. Orthop. Rel. Res. 252, 276.
156. Wozney, J. (1992) The bone morphogenetic protein family and osteogensis. Mol. Reprod. Dev. 32, 160-167.
157. Yamaguchi, J. P. and Rossant, J. (1995) Fibroblast growth factor in mammalian development. Curr. Opin. Genet. Dev. 5, 485-491.
158. Yang, Z., Oemar, B. S., Carrel, T., et al. (1988) Different proliferation properties of smooth muscle cells of human arterial and venous bypass vessels. Role of PDGF receptors mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors. Circulation 97, 181-187.
159. Yasko, A. W., Lane, J. M., Fellinger, E. J., et al. (1992) The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J. Bone Joint Surg. 74, 659-670.
160. Younger, E. M. and Chapman, M. (1989) Morbidity at bone graft donor sites. J. Orthop. Trauma 3, 192-195.
161. Zellin, G., Alberius, P., and Linde, A. (1998) Autoclaved bone for craniofacial reconstruction: effects of supplementation with bone marrow or recombinant human fibroblast growth factor-2. Plast. Reconstr. Surg. 102, 792-800. (Pubitemid 28402623)
162. Zhang, A., Chen, J., and Jin, D. (1998) Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta. Biochem. Biophys. Res. Commun. 251, 190-194. (Pubitemid 28498084)